The World Health Organisation (WHO) has said that preliminary results from clinical trials of therapeutics against COVID-19 are expected in three weeks. "We're also looking forward to results from two clinical trials of therapeutics prioritised by the WHO R&D Blueprint," said WHO Director-General Tedros Adhanom Ghebreyesus. One of the trials he referred to was the combination of two drugs for HIV, lopinavir and ritonavir, while the other is testing an antiviral called remdesivir. “We expect preliminary results in three weeks,” he added. Remdesivir is a drug developed by a US pharmaceutical company. It has shown good antiviral activity against SARS and MERS in previous cell and animal experiments. It has also shown fairly good antiviral activity against the COVID-19 at the cellular level.
Eat fruit, vegetables for better memory, healthy heart
Researchers have found that high consumption of fruit and vegetables is linked to lowered odds of memory loss and its co-morbid heart disease. For the study, published in the International Journal of Public Health, the researchers found strong links between certain food groups, memory loss and co-morbid heart disease or diabetes. The study found that higher consumption of protein-rich foods was associated with a better memory. — Agencies
Join Whatsapp Channel of The Tribune for latest updates.